Quick answers
- What is Xyzal?
- Xyzal is a brand name of Levocetirizine dihydrochloride, a prescription medicine. The FDA NDC Directory lists 2 Xyzal products in 2 strengths and forms.
- Who makes Xyzal?
- Chattem Sanofi holds the FDA application for Xyzal (NDA022064, approved May 25, 2007).
- Is there a generic or store brand of Xyzal?
- Yes. The FDA NDC Directory lists 16 other products with the same active ingredients, strength and form as a Xyzal product, 16 of them generic. Ask your pharmacist whether one is right for you.
- Has Xyzal been recalled?
- No recall linked to Xyzal products (by their NDC code or label) appears in the FDA enforcement reports we use.
What Xyzal is
Each Xyzal product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Levocetirizine dihydrochloride · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| levocetirizine dihydrochloride 0.5 mg/mL solution (oral) | Xyzal | 4 products, 3 companies | DailyMed |
| levocetirizine dihydrochloride 5 mg tablet, film coated (oral) | Xyzal | 12 products, 9 companies | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Levocetirizine dihydrochloride →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| NDA022064 | Chattem Sanofi | May 25, 2007 | 2 |
Companies that list Xyzal
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Xyzal products.
- Chattem, Inc.2 products
Recalls
No recall linked to Xyzal products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.